wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38392673-85B6AB11-48F4-4002-BD94-BF9C674C5CBF
Q38392673-85B6AB11-48F4-4002-BD94-BF9C674C5CBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392673-85B6AB11-48F4-4002-BD94-BF9C674C5CBF
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.
P2860
Q38392673-85B6AB11-48F4-4002-BD94-BF9C674C5CBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392673-85B6AB11-48F4-4002-BD94-BF9C674C5CBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c5f93c7e83bbd650ae488e2becb24e1779524d4
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.